Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-11

Clinical Trial Update: Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy of hydroxychloroquine, telmisartan, and azithromycin in hospitalized elderly patients with COVID-19 was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • Hydroxychloroquine (hydroxychloroquine)
  • Telmisartan (Telmisartan)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: COVID-19 Infection | Phase 3 | Status: TERMINATED